A large-scale evaluation of peptide vaccines against foot-and-mouth disease: Lack of solid protection in cattle and isolation of escape mutants

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 2606-2614

  Taboga, Oscar ^a   Tami, Cecilia ^a   Carrillo, Elisa ^a   Núñez, Jose Ignacio ^b   Rodríguez, Ana ^b,e   Sáiz, Juan Carlos ^c,d   Blanco, Esther ^b   Valero, María Luz ^d   Roig, Xavier ^d   Camarero, Julio A ^d,f   Andreu, David ^d   Mateu, Mauricio G ^c   Giralt, Ernest ^d   Domingo, Esteban ^c   Sobrino, Francisco ^b,c   Palma, Eduardo L ^a  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b INIA   (Spain)

^c CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; FOOT AND MOUTH DISEASE VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; CATTLE; CONTROLLED STUDY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE RESPONSE; INFECTION PREVENTION; INTRADERMAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS MUTANT; VIRUS NEUTRALIZATION;

EID: 0030999059     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.2606-2614.1997     Document Type: Article

References (80)

1. Acharya, R., E. Fry, D. Stuart, G. Fox, D. J. Rowlands, and F. Brown. 1989. The three dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337:709-716.
2. Anderer, F. A., and H. D. Schlumberger. 1965. Properties of different artificial antigens immunologically related to tobacco mosaic virus. Biochim. Biophys. Acta 97:503-509.
3. Arnon, R., E. Maron, M. Sela, and C. B. Anfinsen, 1971. Antibodies reactive with native lysozyme elicited by a completely synthetic antigen. Proc. Natl. Acad. Sci. USA 68:1450-1455.
4. Arnon, R., and M. Sela. 1969. Antibodies to a unique region in lysozyme provoked by a synthetic antigen conjugate. Proc. Natl. Acad. Sci. USA 62: 163-170.
5. Atassi, M. Z., and R. G. Webster. 1983. Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 80:840-844.
6. Bachrach, H. L. 1968. Foot and mouth disease virus. Annu. Rev. Microbiol. 22:201-244.
7. T: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavages. Intervirology 12:65-72.
8. Bahnemann, H. G. 1974. Binary ethylenimine as inactivant for foot and mouth disease virus and its application for vaccine production. Arch. Virol. 47:47-56.
9. Barteling, S. J., and J. Vreeswijk. 1991. Developments in foot-and-mouth disease vaccines. Vaccine 9:75-88.
10. Barteling, S. J., and R. Woortmeyer. 1987. Multiple variants in foot-and-mouth disease virus (FMDV) populations: the achilles heel for peptide and rec. DNA vaccines? Dev. Biol. Stand. 66:511-520.
11. Beck, E., and K. Strohmaier. 1987. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J. Virol. 61: 1621-1629.
12. Bittle, J. L., R. A. Houghten, H. Alexander, T. M. Shinnick, J. G. Sutcliffe, R. A. Lerner, D. J. Rowlands, and F. Brown. 1982. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30-33.
13. Borrás-Cuesta, F., A. Petit-Camurdan, and Y. Fedon. 1987. Engineering of immunogenic peptide by co-linear synthesis of determinants recognized by B and T cells. Bur. J. Immunol. 17:1213-1215.
14. Borrego, B., J. A. Camarero, M. G. Mateu, and E. Domingo. 1995. A highly divergent antigenic site of foot-and-mouth disease virus retains its immunodominance. Viral Immunol. 8:11-18.
15. Brown, F. 1989. Towards a molecular vaccine for foot-and-mouth disease, p. 179-191. In B. L. Semler and E. Ehrenfeld (ed.), Molecular aspects of picornavirus infection and detection. American Society for Microbiology, Washington, D.C.
16. Brown, F. 1992. New approaches to vaccination against foot-and-mouth disease. Vaccine 10:1022-1026.
17. Brown, F. 1995. Antibody recognition and neutralization of foot-and-mouth disease virus. Semin. Virol. 6:243-248.
18. Carreño, C., X. Roig, J. Cairó, J. Camarero, M. G. Mateu, E. Domingo, E. Giralt, and D. Andreu. 1992. Studies on antigenic variability of C strains of foot-and-mouth disease virus by means of synthetic peptides and monoclonal antibodies. Int. J. Peptide Protein Res. 39:41-47.
19. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
20. Collen, T. 1994. Foot-and-mouth disease virus (aphthovirus): viral T cell epitopes, p. 173-197. In B.M.L. Goddeevis and I. Morrison (ed.), Cell-mediated immunity in ruminants. CRC Press Inc., Boca Raton, Fla.
21. Collen, T., and T. R. Doel. 1990. Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J. Gen. Virol. 71:309-315.
22. Collen, T., R. DiMarchi, and T. Doel. 1991. T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J. Immunol. 146:749-755.
23. Cox, J. H., J. Ivanyi, D. B. Young, J. R. Lamb, A. D. Syred, and M. J. Francis. 1988. Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur. J. Immunol. 18:2015-2019.
24. DiMarchi, R., G. Brooke, C. Gale, V. Cracknell, T. Doel, and N. Mowat. 1986. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639-641.
25. Doel, T. R., C. Gale, C. M. C. F. Do Amaral, G. Mulcahy, and R. DiMarchi. 1990. Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. J. Virol. 64:2260-2264.
26. Domingo, E. 1989. RNA virus evolution and the control of viral disease. Prog. Drug Res. 33:93-133.
27. Domingo, E., C. Escarmís, M. A. Martínez, E. Martínez-Salas, and M. G. Mateu. 1992. Foot-and-mouth disease virus populations are quasispecies. Curr. Top. Microbiol. Immunol. 176:33-47.
28. Domingo, E., M. Dávila, and J. Ortín. 1980. Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth disease virus. Gene 11:333-346.
29. Domingo, E., and J. J. Holland. 1992. Complications of RNA heterogeneity for the engineering of virus vaccines and antiviral agents, p. 13-32. In J. K. Setlow (ed.), Genetic engineering, principles and methods, vol. 14. Plenum Press, New York, N.Y.
30. Domingo, E., and J. J. Holland. 1994. Mutation rates and rapid evolution of RNA virus, p. 161-183. In S. S. Morse (ed.), The evolutionary biology of viruses. Raven Press Ltd., New York, N.Y.
31. Domingo, E., M. G. Mateu, M. A. Martínez, J. Dopazo, A. Moya, and F. Sobrino. 1990. Genetic variability and antigenic diversity of foot-and-mouth disease virus, p. 233-266. In E. Kurstak, R. G. Marusyk, S. A. Murphy, and M. H. V. Van-Regenmortel (ed.), Applied virology research, vol. 2. Virus variation and epidemiology. Plenum Publishing Corp., New York, N.Y.
32. Fox, G., N. Parry, P. V. Barnett, B. McGinn, D. J. Rowlands, and F. Brown. 1989. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (argine-glycine-aspartic acid). J. Gen. Virol. 70:625-637.
33. Francis, M. J., C. M. Fry, D. J. Rowlands, J. L. Bittle, R. A. Houghten, R. A. Lerner, and F. Brown. 1987. Immune response to uncoupled peptides of foot-and-mouth disease virus. Immunology 61:1-6.
34. Francis, M. J., G. Z. Hastings, A. D. Syred, B. McGinn, F. Brown, and D. J. Rowlands. 1987. Non-responsiveness to a foot-and-mouth disease virus peptide overcome by addition of foreign helper T-cell determinants. Nature 300:168-170.
35. García-Valcárcel, M. 1993. Cellular immune recognition of foot-and-mouth disease virus and derived antigens. Ph.D. thesis. University of Hertfordshire, Hertfordshire, England.
36. Glass, E. J., R. A. Oliver, T. Collen, T. R. Doel, R. DiMarchi, and R. L. Spooner. 1991. MHC Class II restricted recognition of FMDV peptides by bovine T cells. Immunology 74:594-599.
37. Glass, E. J., and P. Millar. 1995. Bovine T cells preferentially recognize non-viral spacer epitopes in a putative FMDV vaccinal peptide. Vaccine 13:225-229.
38. Golvano, J., J. J. Lasarte, P. Sarobe, A. Gullón, J. Prieto, and F. Borrás-Cuesta. 1990. Polarity of immunogens: implications for vaccine design. Eur. J. Immunol. 20:2363-2366.
39. Green, N., H. Alexander, A. Olson, S. Alexander, T. M. Shinnick, J. G. Sutcliffe, and R. A. Lernen 1982. Immunogenic structure of the influenza virus hemagglutinin. Cell 28:477-487.
40. Kaaden, O. R., K. H. Adam, and K. Strohmaier. 1977. Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus. J. Gen. Virol. 34: 397-400.
41. Kleid, D. G., D. Yansura, B. Small, D. Dowbenko, D. M. Moore, M. J. Grubman, P. D. McKercher, D. O. Morgan, B. H. Robertson, and H. L. Bachrach. 1981. Cloned viral protein vaccine for foot and mouth disease: responses in cattle and swine. Science 214:1125-1129.
42. Küpper, H., W. Keller, C. Kurz, S. Fross, H. Schaller, R. Franze, K. Strohmaier, O. Marquardt, V. G. Zaslavsky, and P. H. Hofschneider. 1981. Cloning of cDNA of major antigen of foot-and-mouth disease virus and expression in E. coli. Nature 289:555-559.
43. Lerner, R. A., N. Green, H. Alexander, F.-T. Liu, J. G. Sutcliffe, and T. M. Shinnick. 1981. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dan particles. Proc. Natl. Acad. Sci. USA 78:3403-3407.
44. Martínez, M. A., J. Hernández, M. E. Piccone, E. L. Palma, E. Domingo, N. Knowles, and M. G. Mateu. 1991. Two mechanisms of antigenic diversification of foot-and-mouth disease virus. Virology 184:695-706.
45. Mason, P. W., E. Rieder, and B. Baxt. 1994. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can he bypassed an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA 91:1932-1936.
46. Mateu, M. G. 1995. Antibody recognition of picornaviruses and escape from neutralization: a structural view. Virus Res. 38:1-24.
47. Mateu, M. G., D. Andreu, and E. Domingo. 1995. Antibodies raised in a natural host and monoclonal antibodies recognize similar antigenic features of foot-and-mouth disease virus. Virology 210:120-127.
48. Mateu, M. G., J. A. Camarero, E. Giralt, D. Andreu, and E. Domingo. 1995. Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206:298-306.
49. Mateu, M. G., J. L. Da Silva, E. Rocha, D. L. De Brum, A. Alonso, L. Enjuanes, E. Domingo, and H. Barahona. 1988. Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Virology 166:113-124.
50. Mateu, M. G., J. Hernández, M. A. Martínez, D. Feigelstock, S. Lea, J. J. Pérez, E. Giralt, D. Stuart, E. L. Palma, and E. Domingo. 1994. Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites. J. Virol. 68:1407-1417.
51. Mateu, M. G., M. A. Martínez, L. Capucci, D. Andreu, E. Giralt, F. Sobrino, E. Brocchi, and E. Domingo. 1990. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J. Gen. Virol. 71:629-637.
52. Mateu, M. G., E. Rocha, O. Vicente, F. Vayreda, C. Navalpotro, D. Andreu, E. Pedroso, E. Giralt, L. Enjuanes, and E. Domingo. 1987. Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Res. 8:261-274.
53. Mateu, M. G., M. A. Martínez, E. Rocha, D. Andreu, J. Parejo, E. Giralt, F. Sobrino, and E. Domingo. 1989. Implications of a quasispecies genome structure: affect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 86:5883-5887.
54. Mateu, M. G., N. Sevilla, et al. Unpublished data.
55. McCullough, K. C., F. De Simone, E. Brocchi, L. Capucci, J. R. Crowther, and U. Kihm. 1992. Protective immune response against foot-and-mouth disease. J. Virol. 66:1835-1840.
56. Meyer, R. F., M. Pacciarini, E. J. Hilyard, S. Ferrari, V. N. Vakharia, G. Donini, E. Brocchi, and T. W. Molitor. 1994. Genetic variation of foot-and-mouth disease virus from field outbreaks to laboratory isolation. Virus Res. 32:299-312.
57. Morgan, D. O., and D. M. Moore. 1990. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. Am. J. Vet. Res. 51:40-45.
58. Mulcahy, G., C. Gale, P. Robertson, S. Iyisan, R. D. DiMarchi, and T. R. Doel. 1990. Isotype responses of infected virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine 8:249-256.
59. Müller, G. M., M. Shapira, and R. Arnon. 1982. Antiinfluenza response achieved by immunization with a synthetic conjugate. Proc. Natl. Acad. Sci. USA 79:569-573.
60. Pereira, H. G. 1981. Foot-and-mouth disease, p. 333-363. In E. P. J. Gibbs (ed.), Virus diseases of food animals, vol. 2. Academic Press, New York. N.Y.
61. Pfaff, E., M. Mussgay, H. O, Böhm, G. E. Schultz, and H. Schaller. 1982. Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO J. 1:869-874.
62. Piccone, M. E., G. Kaplan, L. Giavedoni, E. Domingo, and E. L. Palma. 1988. VP1 of serotype C foot-and-mouth disease viruses: long-term conservation of sequences. J. Virol. 62:1469-1473.
63. Pinto, A., and A. J. M. Garland. 1979. Immune response to virus infection-associated (VIA) antigen in cattle repeatedly vaccinated with foot-and-mouth inactivated by formalin or acetylethyleneimine. J. Hyg. 82:41-50.
64. Rodríguez, A., J. C. Sáiz, I. S. Nombela, D. Andreu, and F. Sobrino. 1994. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus: identification of T helper epitopes in VP1. Virology 205:24-33.
65. Rowlands, D. J., B. E. Clarke, A. R. Carroll, F. Brown, B. H. Nicholson, J. L. Bittle, R. A. Houghten, and R. A. Lerner. 1983. Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature 306:694-697.
66. Rivenson, S., A. Sadir, O. Gaggino, F. Marcovechio, O. Zabal, and O. Laporte. 1982. Estudio comparativo en bovinos de dos vacunas antiaftosa: oleosa e hidroxisaponinada. Rev. Med. (Buenos Aires) 63:364-370.
67. Rueckert, R. R. 1996. Picornaviridae: the virus and their replication, p. 609-654. In B. N. Fields et al. (ed.), Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa.
68. Sáiz, J. C., A. Rodríguez, M. Gonzalez, F. Alonso, and F. Sobrino. 1992. Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J. Gen. Virol. 73:2601-2607.
69. Sáiz, J. C., F. Sobrino, and J. Dopazo. 1993. Molecular evolution of foot-and-mouth disease virus type O. J. Gen. Virol. 74:2281-2285.
70. Saw, D. M., C. M. Stanley, C. D. Partidos, and M. Steward. 1993. Influence of the T-helper epitope on the liter and affinity of antibodies to B-cell epitopes after co-immunization. Mol. Immunol. 30:961-968.
71. Schwartz, R. H. 1986. The value of synthetic peptides as vaccines for eliciting T-cell immunity. Curr. Top. Microbiol. Immunol. 130:79-85.
72. Skinner, H. 1953. One week old white mice as test animals in foot-and-mouth disease research. Proc. XV Int. Congr. Stockholm 1:195.
73. Sobrino, F. Unpublished data.
74. Strohmaier, K., R. Franze, and K. H. Adam. 1982. Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59:295-306.
75. van Bekkum, J. G. 1969. Correlation between serum antibody level and protection against challenge with FMD, p. 38-41. In Session of the Research Group of the standing Technical Committee of the European Commission for the Control of FMD, Brescia. Italy. Food and Agriculture Organization, Rome, Italy.
76. Van Lierop, M.-J. C., P. R. Nilsson, J. P. A. Wagenaar, J. M. van Noort, J. D. M. Campbell, E. J. Glass, I. Joosten, and E. Hensen. 1995. The influence of MHC polymorphism on the selection of T-cell determinants of foot-and-mouth disease virus in cattle. Immunology 84:79-85.
77. Van Lierop, M.-J. C., J. P. A. Wagenaar, J. M. van Noort, and E. J. Hensen. 1995. Sequences derived from the highly antigenic VP1 region 140-160 of foot-and-mouth disease virus do not prime for a bovine T-cell response against intact virus. J. Virol. 69:4511-4514.
78. Verdaguer, N., M. G. Mateu, D. Andreu, E. Giralt, E. Domingo, and I. Fita. 1995. Structure of the major antigen loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. EMBO J. 14:1690-1696.
79. Walter, G., K.-H. Scheidtmann, A. Carbone, A. P. Landano, and R. F. Doolittle. 1980. Antibodies specific for the carboxy-and amino-terminal regions of simian virus 40 large tumor antigen. Proc. Natl. Acad. Sci. USA 77:5197-5200.
80. Weidt, G., W. Deppert, O. Utermöhlen, J. Heukeshoven, and F. Lehman-Grube. 1995. Emergence of virus escape mutants after immunization with epitope vaccines. J. Virol. 69:7147-7151.